US 7,405,192 B2Granted

Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma

AssigneesAlcon Inc., University of North Texas Health Science Center

InventorsAbbot F. Clark, Robert J. Wordinger

Life of this patent

Estimating the term…

Abstract

The present invention provides methods and kits for diagnosing and treating glaucoma.

Claims8

Dependent claims

A method for treating glaucoma comprising administering to a patient in need thereof a composition comprising human bone morphogenic protein 4 (hBMP4), wherein the composition is administered by direct delivery to the eye of the patient.

Dependencies are inferred from the claim text.

Facts

Application: 10/286,152Filed 31 Oct 2002 · us provisional application
Priority: 31 Oct 2001
Published: US 2003/0134308 A117 Jul 2003
Granted: 29 Jul 2008
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

G01N 33/5023
For testing non-proliferative effects: on expression patterns
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 27/00
Drugs for disorders of the senses
A61P 27/06
Ophthalmic agents: antiglaucoma agents or miotics

Family

Application60/334,852Us provisional application · filed 31 Oct 2001
US 2003/0134308 A1Pre-grant publication · published 17 Jul 2003
US 7,405,192 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results